Option chain shows key data for Bavarian Nordic's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Bavarian Nordic.

Bavarian Nordic (OTC:BVNRY) Stock, Option Chain

Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Congo Worst Affected

Biotech

Government

News

Health Care

Contracts

General

BVNKF

BVNRY

The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF.

UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat

Moderna

Large Cap

BNTX

MRNA

Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic&#39;s Jynneos in reducing severe disease in monkeys.

Moderna&#39;s Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows

Media

The European Commission&#39;s first delivery of mpox vaccines to Congo aims to combat the outbreak, despite challenges in distribution and approval.

Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic

BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S

Comments

Bavarian Nordic

Bavarian Nordic (BVNRY) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell